Scleroderma and Vasculitis are major areas of investigation and clinical care at HSS. We have been a site for pivotal trials in Vasculitis, and with the establishment of the Rudolph Rupert Scleroderma Center have emerged as a leading institution for scleroderma research. Myositis and related conditions are also areas of focus. We have created an infrastructure for clinical, translational, and basic research in Scleroderma, Myositis and Vasculitis, as well as for community outreach and patient and physician education.
HSS has been instrumental in bringing attention to Scleroderma, Vasculitis and Myositis. We here at the SVM Center want to further those efforts by highlighting these conditions throughout the year. Please join us as we spread awareness in:
Our hope is to not only to bring these diseases to light, but to also bring this community of patients together in their fight.
Below is a multimedia recording of a talk on patient self-advocacy for people with scleroderma, presented at the SVM Center on October 2, 2018.